MX2011009093A - Metodo para disolver agentes antimicoticos, y composiciones con una alta concentracion de agentes antimicoticos, apropiado para su aplicacion a las uñas. - Google Patents

Metodo para disolver agentes antimicoticos, y composiciones con una alta concentracion de agentes antimicoticos, apropiado para su aplicacion a las uñas.

Info

Publication number
MX2011009093A
MX2011009093A MX2011009093A MX2011009093A MX2011009093A MX 2011009093 A MX2011009093 A MX 2011009093A MX 2011009093 A MX2011009093 A MX 2011009093A MX 2011009093 A MX2011009093 A MX 2011009093A MX 2011009093 A MX2011009093 A MX 2011009093A
Authority
MX
Mexico
Prior art keywords
antifungal agent
nail
application
dissolving
compositions
Prior art date
Application number
MX2011009093A
Other languages
English (en)
Inventor
Nathalie Willcox
Claire Mallard
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2011009093A publication Critical patent/MX2011009093A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona una composición farmacéutica la cual comprende: - un agente antimicótico de la clase de las alilaminas o de las morfolinas, en una concentración de por lo menos 5%; - un sistema solvente ternario que comprende agua; por lo menos un alcanol C2-C8 de cadena ramificada o recta; por lo menos un glicol; la cantidad total de agua que representa más del 30% (peso/peso) de la composición. Esta composición está prevista para aplicarse a la uña para el tratamiento de onicomicosis.
MX2011009093A 2009-03-06 2010-03-05 Metodo para disolver agentes antimicoticos, y composiciones con una alta concentracion de agentes antimicoticos, apropiado para su aplicacion a las uñas. MX2011009093A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20251609P 2009-03-06 2009-03-06
FR0951416A FR2942716B1 (fr) 2009-03-06 2009-03-06 Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
PCT/EP2010/052817 WO2010100252A1 (en) 2009-03-06 2010-03-05 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail

Publications (1)

Publication Number Publication Date
MX2011009093A true MX2011009093A (es) 2011-09-27

Family

ID=41056884

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009093A MX2011009093A (es) 2009-03-06 2010-03-05 Metodo para disolver agentes antimicoticos, y composiciones con una alta concentracion de agentes antimicoticos, apropiado para su aplicacion a las uñas.

Country Status (11)

Country Link
EP (1) EP2403476A1 (es)
JP (1) JP2012519669A (es)
KR (1) KR20110121702A (es)
CN (1) CN102341092A (es)
AU (1) AU2010220266A1 (es)
BR (1) BRPI1006666A2 (es)
CA (1) CA2753638A1 (es)
FR (1) FR2942716B1 (es)
MX (1) MX2011009093A (es)
RU (1) RU2011140574A (es)
WO (1) WO2010100252A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
EP2672962B1 (en) * 2011-02-11 2015-03-25 Moberg Pharma AB Novel antifungal composition
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
AU2014329421B2 (en) 2013-10-03 2018-08-02 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
KR102612453B1 (ko) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 항­감염 방법，조성물，및 장치
CN113368215A (zh) * 2014-10-21 2021-09-10 赫希玛有限公司 一种治疗方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug

Also Published As

Publication number Publication date
JP2012519669A (ja) 2012-08-30
WO2010100252A1 (en) 2010-09-10
RU2011140574A (ru) 2013-04-20
FR2942716A1 (fr) 2010-09-10
BRPI1006666A2 (pt) 2016-04-19
FR2942716B1 (fr) 2011-04-15
EP2403476A1 (en) 2012-01-11
CN102341092A (zh) 2012-02-01
AU2010220266A1 (en) 2011-09-08
CA2753638A1 (en) 2010-09-10
KR20110121702A (ko) 2011-11-08

Similar Documents

Publication Publication Date Title
MX2011009093A (es) Metodo para disolver agentes antimicoticos, y composiciones con una alta concentracion de agentes antimicoticos, apropiado para su aplicacion a las uñas.
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
EA201070421A1 (ru) Микрорибонуклеиновые кислоты
CR10479A (es) Modulares bencimidazolicos de vr1
EA201290389A1 (ru) Применение 1,3-дифенилпроп-2-ен-1-оновых производных для лечения заболеваний печени
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
BRPI0608604B8 (pt) moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
CL2008001839A1 (es) Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
MX2009005460A (es) (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano.
MX358290B (es) Composiciones que contienen al menos un compuesto que contiene grupos carbamoilsulfonato y su uso como agentes de curtido.
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
ATE528990T1 (de) Desinfektions- und entkeimungsmittel
ATE509931T1 (de) Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür
MX340993B (es) Agentes de suministro de acido fenilalquilcarboxilico.
BR112012014737A2 (pt) calconas como realçador de agentes antimicrobianos
MX2012006490A (es) Inhibidores azociclicos de hidrolasa de amidas de acidos grasos.
HRP20150507T1 (hr) Novi antifungalni pripravak
SG158091A1 (en) Imidazoazepinone compounds
WO2011051968A3 (en) Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof
BRPI0603785A (pt) lubrifcante pessoal borrifável
WO2013007637A3 (en) Cosmetic compositions in the form of water-in-oil emulsions including a jasmonic acid derivative and a silicone surfactant
SV2008002512A (es) Derivados de aminoacidos ref. pc32769a
ATE509015T1 (de) Deuterierte piperazinderivate als verbindungen gegen angina
ATE474574T1 (de) Imidazoazephinonverbindungen
DK2051687T3 (da) Emulsionssammensætning til brug i et produkt til hudpleje eller hårfjernelse